Oncosil Medical Ltd
ASX Code
OSL
Sector
Pharmaceuticals- Biotechnology & Life Sciences
Investor Centre
https://www.oncosil.com.au/global/medical-investor-centre/cancer-research-investment
Website
https://www.oncosil.com.au/
About
OncoSil Medical is a medical device company seeking to advance radiation for cancer patients. OncoSil Medical’s lead product, OncoSilTM is a targeted radioactive isotope (Phosphorus-32), implanted directly into a patient’s pancreatic tumours via an endoscopic ultrasound. Treatment with the OncoSilTM is intended to deliver more concentrated and localised beta radiation compared to external beam radiation. OncoSil Medical has conducted six clinical studies with positive results on tolerability, safety and efficacy. CE Marking has been granted for the OncoSilTM device which can be marketed in the European Union and the United Kingdom. The OncoSilTM device has also been classified a Breakthrough Device in the European Union and the United Kingdom.
News
| Oncosil Medical - ShareCafe Hidden Gems Webinar Presentation |